IRIS - Res&Arch Institutional Research Information System - Research & Archive

DI FILIPPO, MASSIMILIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.491
AS - Asia 3.829
EU - Europa 3.228
SA - Sud America 721
AF - Africa 99
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 12.378
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.359
SG - Singapore 1.759
IT - Italia 621
CN - Cina 549
BR - Brasile 547
HK - Hong Kong 488
IE - Irlanda 486
RU - Federazione Russa 480
VN - Vietnam 402
FR - Francia 273
DE - Germania 250
UA - Ucraina 249
SE - Svezia 242
FI - Finlandia 174
GB - Regno Unito 120
KR - Corea 119
BD - Bangladesh 107
IN - India 79
RO - Romania 64
AR - Argentina 55
CA - Canada 51
NL - Olanda 48
TR - Turchia 45
MX - Messico 43
IQ - Iraq 40
CZ - Repubblica Ceca 39
JP - Giappone 38
PL - Polonia 38
ID - Indonesia 37
ZA - Sudafrica 32
EC - Ecuador 29
PK - Pakistan 29
AT - Austria 25
BE - Belgio 25
CO - Colombia 23
SA - Arabia Saudita 23
VE - Venezuela 23
UZ - Uzbekistan 22
ES - Italia 17
PH - Filippine 16
PY - Paraguay 14
MA - Marocco 13
TN - Tunisia 13
CH - Svizzera 12
LB - Libano 12
LT - Lituania 12
CL - Cile 11
GR - Grecia 11
JM - Giamaica 11
HR - Croazia 9
NI - Nicaragua 8
AE - Emirati Arabi Uniti 7
BO - Bolivia 6
EG - Egitto 6
ET - Etiopia 6
KE - Kenya 6
KZ - Kazakistan 6
UY - Uruguay 6
DZ - Algeria 5
JO - Giordania 5
PE - Perù 5
AZ - Azerbaigian 4
BA - Bosnia-Erzegovina 4
IL - Israele 4
KG - Kirghizistan 4
PA - Panama 4
PT - Portogallo 4
TW - Taiwan 4
BB - Barbados 3
BG - Bulgaria 3
CG - Congo 3
DO - Repubblica Dominicana 3
IR - Iran 3
NP - Nepal 3
OM - Oman 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
AU - Australia 2
BW - Botswana 2
BY - Bielorussia 2
DK - Danimarca 2
EU - Europa 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
ME - Montenegro 2
MM - Myanmar 2
MY - Malesia 2
NO - Norvegia 2
QA - Qatar 2
RS - Serbia 2
SN - Senegal 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AD - Andorra 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BF - Burkina Faso 1
BH - Bahrain 1
Totale 12.346
Salva come PNG Salva come JPEG
Città #
Singapore 1.271
Chandler 512
Hong Kong 486
Dublin 485
San Jose 455
Ashburn 303
Perugia 275
Boardman 230
San Mateo 220
Santa Clara 183
Moscow 174
Beijing 147
Altamura 139
Jacksonville 130
Lauterbourg 129
Dong Ket 121
Seoul 119
Munich 112
Medford 111
Princeton 111
Lawrence 105
Los Angeles 98
Wilmington 93
Ho Chi Minh City 88
Andover 86
Ann Arbor 81
New York 68
The Dalles 67
Des Moines 61
Hanoi 56
Turku 54
Piscataway 49
Helsinki 43
São Paulo 43
Frankfurt am Main 40
Redmond 40
Bucharest 35
Tokyo 35
Falls Church 34
Orem 29
Brno 27
Warsaw 26
Chennai 25
Denver 25
Saint Petersburg 25
Brooklyn 24
Atlanta 23
Chicago 23
Dallas 23
Boston 22
Houston 22
Amsterdam 21
Montreal 21
Brussels 20
Nuremberg 20
Johannesburg 19
London 19
Norwalk 19
Redwood City 18
Council Bluffs 17
Woodbridge 17
Haiphong 16
Quito 16
Stockholm 16
Vienna 16
Phoenix 15
Rio de Janeiro 15
Columbus 14
Rome 14
San Francisco 14
Ankara 13
Hefei 13
Poplar 13
Tashkent 13
Manchester 12
Timisoara 12
Izmir 11
Biên Hòa 10
Buffalo 10
Dhaka 10
Guangzhou 10
Riyadh 10
Baghdad 9
Belo Horizonte 9
Campinas 9
Caracas 9
Da Nang 9
Den Haag 9
Falkenstein 9
Kingston 9
San Paolo di Civitate 9
Shenzhen 9
Toronto 9
Brasília 8
Managua 8
Medellín 8
Mexico City 8
Milan 8
Porto Alegre 8
Salvador 8
Totale 7.802
Salva come PNG Salva come JPEG
Nome #
Alpha-Synuclein Produces Early Behavioral Alterations Via Striatal Cholinergic Synaptic Dysfunction by Interacting with GluN2D N-Methyl-D-Aspartate Receptor Subunit 219
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration 172
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 155
Synaptic plasticity and experimental autoimmune encephalomyelitis: implications for multiple sclerosis 150
Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis 140
Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis 138
Hippocampal epileptogenesis in autoimmune encephalitis 132
Acetyl-L-Carnitine selectively prevents post-ischemic LTP via a possible action on mitochondrial energy metabolism. 132
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment 126
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis 126
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation 124
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 124
Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease 124
Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition. 123
Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis 123
A2A Adenosine Receptor Antagonism Enhances Synaptic and Motor Effects of Cocaine via CB1 Cannabinoid Receptor Activation. 122
Effects of central and peripheral inflammation on hippocampal synaptic plasticity 120
Low doses of Perampanel protect striatal and hippocampal neurons against in vitro ischemia by reversing the ischemia-induced alteration of AMPA receptor subunit composition 118
A2A adenosine receptor antagonists protect the striatum against rotenone-induced neurotoxicity 117
Plasticity and repair in the post-ischemic brain 116
Visual pathway involvement in multiple sclerosis: Look straight in the eyes 116
Persistent activation of microglia and NADPH drive hippocampal dysfunction in experimental multiple sclerosis 115
2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes 115
Endogenous 17β-estradiol is required for activity-dependent long-term potentiation in the striatum: interaction with the dopaminergic system 114
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease. 112
Extracranial Venous Drainage Pattern in Multiple Sclerosis and Healthy Controls: Application of the 2011 Diagnostic Criteria for Chronic Cerebrospinal Venous Insufficiency 111
Ischemic bilateral hippocampal dysfunction during transient global amnesia. 107
ACh/dopamine crosstalk in motor control and reward: a crucial role for alpha 6-containing nicotinic receptors? 107
Critical role of calcitonin gene-related peptide receptors in cortical spreading depression. 107
Lower urinary tract symptoms and urodynamic dysfunction in clinically isolated syndromes suggestive of multiple sclerosis 106
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study 103
Basi neurobiologiche dei deficit cognitivi nella malattia di Parkinson 102
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? 102
Memantine reduces neuronal dysfunctions triggered by in vitro ischemia and 3-nitropropionic acid. 101
Ischemic-LTP in striatal spiny neurons of both direct and indirect pathway requires the activation of D1-like receptors and NO/soluble guanylate cyclase/cGMP transmission. 101
Cognitive impairment in multiple sclerosis: lessons from cerebrospinal fluid biomarkers 101
CSF neurochemical profile and cognitive changes in Parkinson's disease with mild cognitive impairment 100
Psychiatric symptoms in multiple sclerosis: a biological perspective on synaptic and network dysfunction 100
Heterozygous X-linked adrenoleukodystrophy-associated myelopathy mimicking primary progressive multiple sclerosis 100
Treatment of multiple sclerosis relapses with high-dose methylprednisolone reduces the evolution of contrast-enhancing lesions into persistent black holes 100
Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis. 99
Region- and age-dependent reductions of hippocampal long-term potentiation and NMDA to AMPA ratio in a genetic model of Alzheimer's disease. 99
Mitochondria and the link between neuroinflammation and neurodegeneration. 98
Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis: a multicenter retrospective study 98
Direct and indirect pathways of basal ganglia: a critical reappraisal. 97
From Synaptic Dysfunction to Neuroprotective Strategies in Genetic Parkinson’s Disease: Lessons From LRRK2 97
Hippocampal synaptic plasticity, memory, and epilepsy: effects of long-term valproic acid treatment. 96
Lacosamide protects striatal and hippocampal neurons from in vitro ischemia without altering physiological synaptic plasticity 96
A microbially produced AhR ligand promotes a Tph1-driven tolerogenic program in multiple sclerosis 94
A pathophysiological link between dystonia, striatal interneurons and neuropeptide Y 93
A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance. 93
Beyond clinical changes: Rehabilitation-induced neuroplasticity in MS 93
A young patient with type C multiple system atrophy and hereditary hemochromatosis. 93
La disfunzione sessuale nei pazienti con sclerosi multipla: prevalenza e impatto dei trattamenti sintomatici 89
Erratum: Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis (Scientific Reports (2016) 6 (20926) DOI: 10.1038/srep20926) 89
Retinopathy during interferon-β treatment for multiple sclerosis: case report and review of the literature 89
Synaptic dysfunction in multiple sclerosis: A red thread from inflammation to network disconnection 88
The distinct role of medium spiny neurons and cholinergic interneurons in the D₂/A₂A receptor interaction in the striatum: implications for Parkinson's disease. 87
Host and Microbial Tryptophan Metabolic Profiling in Multiple Sclerosis 87
CAR T cell-driven cerebrospinal fluid cytokine storm with confounding neurological picture in chemorefractory primary cardiac lymphoma 87
The endocannabinoid system in Parkinson's disease. 83
Epilepsy-induced abnormal striatal plasticity in Bassoon mutant mice. 83
Insights into the pathophysiology of psychiatric symptoms in central nervous system disorders: Implications for early and differential diagnosis 83
Does cerebrospinal fluid neurofilament light chain correlate with psychiatric symptoms severity in multiple sclerosis? 82
Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: A multicentre retrospective study 81
Parkinsonism and cognitive impairment following chronic exposure to potassium cyanide. 81
Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia. 81
Distinct levels of dopamine denervation differentially alter striatal synapticplasticity and NMDA receptor subunit composition. 81
Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis 81
Neuroinflammation and Alzheimer's Disease: A Machine Learning Approach to CSF Proteomics 81
Short-term and long-term plasticity at corticostriatal synapses: Implications for learning and memory. 80
Interferon-β1a modulates glutamate neurotransmission in the CNS through CaMKII and GluN2A-containing NMDA receptors 80
High risk of early conversion to multiple sclerosis in clinically isolated syndromes with dissemination in space at baseline 80
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop) 79
Na+/Ca2+ exchanger maintains ionic homeostasis in the peri-infarct area. 79
Tracing Neurological Diseases in the Presymptomatic Phase: Insights From Neurofilament Light Chain 79
CSF synaptic biomarkers and cognitive impairment in multiple sclerosis 78
Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients. 78
Teaching NeuroImages: Acute tetraparesis: Mind the brain 78
CSF proteome analysis in multiple sclerosis patients by two-dimensional electrophoresis. 78
The no evidence of disease activity (NEDA) concept in MS: impact of spinal cord MRI 78
Ischemic stroke injury is mediated by aberrant Cdk5 77
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 77
An “all-wheel drive” proposal to accelerate clinical research in common and rare neurological diseases 77
Finding a way to preserve mitochondria: New pathogenic pathways in experimental multiple sclerosis 77
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 76
Recurrent hyperCKemia with normal muscle biopsy in a pediatric patient with neuromyelitis optica 76
Impact of post-contrast MRI in the definition of active multiple sclerosis 75
Multiple sclerosis and cognition: synaptic failure and network dysfunction 75
Neurofilament light chain as a biomarker in neurological disorders 75
Expression of ionotropic glutamate receptor GLUR3 and effects of glutamate on MBP- and MOG-specific lymphocyte activation and chemotactic migration in multiple sclerosis patients. 74
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose 72
Cerebrospinal fluid, brain, and spinal cord levels of L-aspartate signal excitatory neurotransmission abnormalities in multiple sclerosis patients and experimental autoimmune encephalomyelitis mouse model 72
Sensitization, glutamate, and the link between migraine and fibromyalgia. 72
Multiple sclerosis and chronic progressive external ophthalmoplegia associated with a large scale mitochondrial DNA single deletion 72
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study 72
Cytokines, synaptic plasticity and network dynamics: a matter of balance 71
New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson's disease. 71
CSF biomarkers of B-cell activation in multiple sclerosis: a clinical perspective 68
Neuroscience: Brain's traffic lights. 68
Totale 9.764
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.102
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.102
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021133 0 0 0 0 0 0 0 0 0 0 0 133
2021/20221.041 13 158 34 46 49 31 13 290 21 82 158 146
2022/20231.742 119 373 23 152 124 188 6 58 627 4 51 17
2023/2024918 38 84 33 61 6 2 164 13 122 32 162 201
2024/20252.227 27 203 82 106 230 175 112 209 390 136 364 193
2025/20265.278 361 368 288 772 705 493 813 276 520 405 192 85
Totale 12.715